Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Phenacetin Production in China Insights and CAS 62-44-2 Analysis for Pharmaceutical Applications

Dec . 13, 2024 13:22 Back to list

Phenacetin Production in China Insights and CAS 62-44-2 Analysis for Pharmaceutical Applications



Phenacetin A Historical Overview and Regulatory Perspective


Phenacetin, chemically known as acetophenetidin, is a non-opioid analgesic and antipyretic agent that was widely used in the medical field for over a century. With the CAS number 62-44-2, phenacetin has a rich history but has also faced significant scrutiny due to its adverse effects and safety profile.


Historical Background

Phenacetin was first synthesized in the late 19th century and made its debut as a pain reliever in 1887. It became popular for its efficacy in alleviating headaches, muscle pain, and fevers. For decades, phenacetin was a common ingredient in over-the-counter medications and combination therapies, often used in conjunction with other analgesics like aspirin and caffeine to enhance its therapeutic effects.


As a member of the analgesic family, phenacetin was marketed for its perceived safety and effectiveness. However, as its usage increased, so did the reports of adverse side effects. In the mid-20th century, concerns regarding the potential toxic effects of phenacetin began to surface, particularly its association with renal toxicity and carcinogenicity. Subsequent studies revealed a concerning link between phenacetin use and an increased risk of renal tumors, leading to a reevaluation of its safety.


Health Risks and Regulatory Actions


In the 1970s and 1980s, the safety of phenacetin was called into question by various health organizations. The drug was linked to nephropathy, a condition characterized by kidney damage, and evidence suggested that individuals with prolonged exposure were at a higher risk of developing serious health issues, including bladder cancer. These findings prompted regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to act.


china phenacetin cas 62-44-2

china phenacetin cas 62-44-2

In 1983, the FDA took the significant step of banning the over-the-counter sale of phenacetin-containing products, following a recommendation from a panel of experts. This ban was later mirrored by other countries, leading to a drastic decline in the usage of phenacetin in medical practice. The drug was ultimately withdrawn from the market in many regions, and alternative analgesics were promoted as safer options for pain relief.


Legacy and Current Alternatives


Today, phenacetin has largely been replaced by safer analgesics such as acetaminophen (paracetamol) and non-steroidal anti-inflammatory drugs (NSAIDs). Acetaminophen, in particular, is considered a go-to pain relief option due to its favorable safety profile when used as directed. The lessons learned from the phenacetin saga have also led to increased regulatory scrutiny of new drugs, emphasizing the importance of comprehensive safety studies prior to market approval.


Moreover, the ongoing research and digital data advancements allow healthcare professionals to better assess the risk-to-benefit ratio of medications. The historical perspective on phenacetin serves as a reminder of the critical need for vigilance in drug safety and the importance of ongoing pharmacovigilance in protecting public health.


Conclusion


In conclusion, phenacetin's journey from a widely used analgesic to a banned substance underscores the complexities of drug safety and efficacy. Although it played a significant role in pain management for many years, the associated health risks ultimately overshadowed its benefits. The case of phenacetin continues to inform modern regulatory practices and reminds us of the paramount importance of patient safety in pharmaceutical development. As we move forward, the emphasis must remain on fostering innovation in pain management that prioritizes efficacy while safeguarding health.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish